International service provider and consulting firm for the healthcare industry, Diapharm, is opening a new Benelux branch in Breda, Netherlands.
The German parent company, Diapharm, is based in Germany. It advises and assists companies with regard to the development, approval and quality assurance of healthcare products across Europe.
The company also develops product innovations, especially for the OTC market.
The newly established Diapharm BV will focus on quality assurance, pharmacovigilance and regulatory affairs for internationally active pharmaceutical companies from the The Benelux Union; the three neighbouring states of the Netherlands, Belgium and Luxembourg.
“Diapharm stands for premium quality and reliability worldwide,” said Bert Verhage, the recently-appointed Manager at Diapharm BV.
“Above all, it provides precisely those international services that have been missing so far from the Benelux market.”
